SG10201807427RA - Method of cleansing the colon - Google Patents
Method of cleansing the colonInfo
- Publication number
- SG10201807427RA SG10201807427RA SG10201807427RA SG10201807427RA SG10201807427RA SG 10201807427R A SG10201807427R A SG 10201807427RA SG 10201807427R A SG10201807427R A SG 10201807427RA SG 10201807427R A SG10201807427R A SG 10201807427RA SG 10201807427R A SG10201807427R A SG 10201807427RA
- Authority
- SG
- Singapore
- Prior art keywords
- colon
- time period
- cleansing solution
- cleansing
- colon cleansing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
- A61K31/77—Polymers containing oxygen of oxiranes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
METHOD OF CLEANSING THE COLON Method of cleansing the colon before a diagnostic, therapeutic or surgical procedure comprising: - administering an effective amount of a first colon cleansing solution; - administering an effective amount of a second colon cleansing solution, the second colon cleansing solution being as defined in the application; whereby the first colon cleansing solution is taken over a time period t(d1) followed by optional additional clear fluid over a time period t(cf1), and then following a time interval t(dose interval), the second colon cleansing solution is taken over a time period t(d2) followed by optional additional clear fluid over a time period t(cf2), whereby the subject undergoes the surgical, therapeutic or diagnostic procedure at a time t2 after the beginning of the colon cleansing method, and whereby the time interval after the completion of the second additional clear fluid and the start of the surgical, therapeutic or diagnostic procedure is t(procedure interval). Figure 1
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261699488P | 2012-09-11 | 2012-09-11 | |
US201361787366P | 2013-03-15 | 2013-03-15 | |
US14/202,098 US20140186470A1 (en) | 2012-09-11 | 2014-03-10 | Compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
SG10201807427RA true SG10201807427RA (en) | 2018-09-27 |
Family
ID=49165735
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10201702005VA SG10201702005VA (en) | 2012-09-11 | 2013-09-10 | Compositions comprising peg and ascorbate |
SG11201501713XA SG11201501713XA (en) | 2012-09-11 | 2013-09-10 | Compositions comprising peg and ascorbate |
SG10202112138QA SG10202112138QA (en) | 2012-09-11 | 2013-09-10 | Compositions comprising peg and sulphate |
SG10201807427RA SG10201807427RA (en) | 2012-09-11 | 2015-03-09 | Method of cleansing the colon |
Family Applications Before (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10201702005VA SG10201702005VA (en) | 2012-09-11 | 2013-09-10 | Compositions comprising peg and ascorbate |
SG11201501713XA SG11201501713XA (en) | 2012-09-11 | 2013-09-10 | Compositions comprising peg and ascorbate |
SG10202112138QA SG10202112138QA (en) | 2012-09-11 | 2013-09-10 | Compositions comprising peg and sulphate |
Country Status (33)
Country | Link |
---|---|
US (9) | US20140186470A1 (en) |
EP (2) | EP2895163B1 (en) |
JP (3) | JP6655391B2 (en) |
KR (5) | KR101771586B1 (en) |
CN (2) | CN105007915B (en) |
AR (1) | AR092500A1 (en) |
AU (2) | AU2013314442C1 (en) |
BR (1) | BR112015005270B1 (en) |
CA (2) | CA2884472C (en) |
CY (1) | CY1121668T1 (en) |
DK (2) | DK2895163T3 (en) |
EA (1) | EA028866B1 (en) |
ES (3) | ES2909386T3 (en) |
HK (1) | HK1206604A1 (en) |
HR (1) | HRP20191007T1 (en) |
HU (1) | HUE043605T2 (en) |
IL (2) | IL237377B (en) |
IN (1) | IN2015DN01704A (en) |
LT (1) | LT2895163T (en) |
ME (1) | ME03413B (en) |
MX (2) | MX359318B (en) |
MY (2) | MY193378A (en) |
NL (1) | NL2011424C2 (en) |
NZ (2) | NZ705499A (en) |
PL (2) | PL2895163T3 (en) |
PT (2) | PT3473248T (en) |
RS (1) | RS58979B1 (en) |
SG (4) | SG10201702005VA (en) |
SI (1) | SI2895163T1 (en) |
TW (2) | TWI756623B (en) |
UA (1) | UA116546C2 (en) |
WO (1) | WO2014040994A1 (en) |
ZA (2) | ZA201501415B (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI535461B (en) * | 2011-03-11 | 2016-06-01 | 諾金私人有限公司 | Colon cleansing solutions,compositions for preparing the solutions,kits comprising the compositions or solutions,and methods for preparing the solutions |
ES2909386T3 (en) * | 2012-09-11 | 2022-05-06 | Norgine Bv | Compositions comprising polyethylene glycol and alkali or alkaline earth metal sulfates for use as colon cleansing compositions |
EP3563838A1 (en) | 2013-03-15 | 2019-11-06 | Braintree Laboratories, Inc. | Dual use oral pharmaceutical composition tablets of suflate salts and methods of use thereof |
EP3116494B8 (en) * | 2014-03-10 | 2021-04-28 | Norgine B.V. | Method of cleansing the colon |
WO2017120385A1 (en) * | 2016-01-06 | 2017-07-13 | California Institute Of Technology | Polymeric compositions and related systems and methods for regulating biological hydrogels |
FR3049464B1 (en) * | 2016-03-29 | 2021-08-06 | Marc Girard | COLIC PREPARATIONS |
WO2019151829A1 (en) * | 2018-02-01 | 2019-08-08 | 주식회사태준제약 | Bowel cleansing composition |
KR20190093491A (en) * | 2018-02-01 | 2019-08-09 | 주식회사태준제약 | Bowel cleansing composition |
JP7011629B2 (en) * | 2019-07-11 | 2022-01-26 | ノージン ビーブイ | How to clean the colon |
CN110339158B (en) * | 2019-08-21 | 2020-11-13 | 扬子江药业集团上海海尼药业有限公司 | Sodium potassium magnesium sulfate oral solution and preparation method thereof |
US20210196748A1 (en) * | 2019-12-30 | 2021-07-01 | Robert Olson | Composition and therapy for treatment of gag reflexes |
KR20220033790A (en) * | 2020-09-10 | 2022-03-17 | 강윤식 | Bowel Cleansing Composition |
KR102467063B1 (en) * | 2021-02-26 | 2022-11-14 | 주식회사태준제약 | Composition for colon cleansing |
Family Cites Families (108)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2187467A (en) | 1939-02-11 | 1940-01-16 | Lilly Co Eli | Cevitamate solution |
US2427692A (en) | 1940-07-29 | 1947-09-23 | Frances R Ruskin | Therapeutic metal cevitamate compositions |
US2481353A (en) | 1946-10-25 | 1949-09-06 | Schnabel Lewis Wilson | Method of manufacturing vitamin concentrates |
US2694719A (en) | 1949-02-12 | 1954-11-16 | Opplt Jan | Method of stabilizing ascorbic acid with alkali-thiosulfate-carbamide-complexes |
US3211614A (en) | 1963-07-10 | 1965-10-12 | Pharmacia Ab | Enema-type laxative composition |
WO1987000754A1 (en) | 1985-08-01 | 1987-02-12 | Braintree Laboratories, Inc. | Low-sodium laxative and lavage formulation |
JPS6295194A (en) | 1985-10-18 | 1987-05-01 | Sekisui Chem Co Ltd | Mineral water producing agent |
JPH0540310Y2 (en) | 1985-12-06 | 1993-10-13 | ||
JP2557111Y2 (en) | 1986-07-11 | 1997-12-08 | 富士電機株式会社 | Commodity remaining amount display device for product storage shelf of vending machine |
DE3807712A1 (en) | 1987-07-25 | 1989-02-02 | Nordend Apotheke Angela Hein | Dry pharmaceutical product for preparing a laxative solution for drinking, and a process for the production of this product |
JPH01125319A (en) | 1987-11-11 | 1989-05-17 | Morishita Seiyaku Kk | Administration composition for whole intestine irrigation liquid |
JP2596764B2 (en) | 1987-11-18 | 1997-04-02 | ルセル森下株式会社 | Intestinal cleansing liquid |
US5274001A (en) * | 1987-12-24 | 1993-12-28 | Borody Thomas J | Orthostatic lavage solutions |
JP2630423B2 (en) | 1988-05-06 | 1997-07-16 | 富山化学工業株式会社 | Low sodium salty seasoning |
JPH0816061B2 (en) | 1988-07-13 | 1996-02-21 | 森下ルセル株式会社 | Intestinal lavage fluid composition and intestinal lavage fluid |
SE465669B (en) | 1988-07-15 | 1991-10-14 | Hanson & Moehring Ab | SALT FOR FOOD SUMMARY AND PROCEDURE FOR ITS PREPARATION |
JPH0263042A (en) | 1988-08-30 | 1990-03-02 | Fuji Photo Film Co Ltd | Radiograph information recorder/reader |
JP2936168B2 (en) | 1988-12-27 | 1999-08-23 | 東ソー株式会社 | Polyolefin production method |
US5540945A (en) | 1989-05-11 | 1996-07-30 | Chugai Seiyaku Kabushiki Kaisha | Pharmaceutical preparations for oral administration that are adapted to release the drug at appropriate sites in the intestines |
JP2557111B2 (en) | 1989-11-27 | 1996-11-27 | フジックス 株式会社 | Method for producing high-concentration magnesium solution, magnesium solution obtained thereby and use thereof |
FR2662442A1 (en) | 1990-05-23 | 1991-11-29 | Midy Spa | N-SUBSTITUTED TRIFLUOROMETHYLPHENYLTETRAHYDROPYRIDINES PROCESS FOR THEIR PREPARATION, INTERMEDIATES THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME |
JPH04112830A (en) | 1990-08-31 | 1992-04-14 | Morishita Pharmaceut Co Ltd | Preparation of liquid composition for cleaning enteric canal |
JP3457012B2 (en) | 1992-01-14 | 2003-10-14 | 富士化学工業株式会社 | Amorphous magnesium citrate granular material and method for producing the same |
CN1045383C (en) | 1993-04-07 | 1999-10-06 | 王慧康 | Medicine composite for curing senile cataract |
JPH06295194A (en) | 1993-04-08 | 1994-10-21 | Matsushita Electric Ind Co Ltd | Signal comparing device |
JP3850891B2 (en) | 1994-03-01 | 2006-11-29 | ゼリア新薬工業株式会社 | Composition having a laxative effect |
US5411745A (en) | 1994-05-25 | 1995-05-02 | Euro-Celtique, S.A. | Powder-layered morphine sulfate formulations |
JP3439559B2 (en) | 1995-02-01 | 2003-08-25 | 三栄源エフ・エフ・アイ株式会社 | How to improve the flavor of food |
AUPN634595A0 (en) | 1995-11-03 | 1995-11-30 | Borody, Thomas Julius | Improved method for colonic evacuation |
CN1150021A (en) | 1996-01-11 | 1997-05-21 | 李智军 | Bowel clearing agent |
US6162464A (en) | 1997-03-31 | 2000-12-19 | Inkine Pharmaceutical, Inc. | Non-aqueous colonic purgative formulations |
JP4092748B2 (en) | 1997-09-05 | 2008-05-28 | ニプロ株式会社 | Intestinal lavage fluid |
JPH11228423A (en) | 1998-02-17 | 1999-08-24 | Ohara Yakuhin Kogyo Kk | Lavaging composition for intestinal tract |
CN1093259C (en) | 1998-04-29 | 2002-10-23 | 宝山钢铁股份有限公司 | Method for measuring emulsion saponification value and miscella content |
CZ9900555A3 (en) | 1999-02-19 | 2000-10-11 | Radomír Ing. Špetík | Method of extracorporeal identification of malignant and another disease of humans and mixture of substances as blood stimulant |
US6444198B1 (en) | 1999-02-22 | 2002-09-03 | Smithkline Beecham Corporation | Effervescent laxatives |
AUPQ847000A0 (en) | 2000-06-29 | 2000-07-27 | Adventures Plus Pty Ltd | Nutrient beverage |
SE518524C2 (en) | 2000-12-21 | 2002-10-22 | Vaederstad Verken Ab | Control device for an agricultural machine |
JP2002207002A (en) | 2001-01-10 | 2002-07-26 | Hitachi Eng Co Ltd | Atmospheric environment simulation system |
CN1143678C (en) | 2001-02-23 | 2004-03-31 | 东北制药总厂 | Medicinal application of VC phosphate ester magnesium |
JP2002265372A (en) | 2001-03-07 | 2002-09-18 | Shimizu Pharmaceutical Co Ltd | Intestinal tract-cleaning agent |
RU2178292C1 (en) | 2001-04-13 | 2002-01-20 | Государственный научный центр колопроктологии Министерства здравоохранения и медицинской промышленности РФ | Preparation for total gastrointestinal tract washing |
JP5041642B2 (en) | 2001-08-30 | 2012-10-03 | 日本製薬株式会社 | Composition for oral intestinal lavage and filling preparation for oral intestinal lavage |
US6592901B2 (en) | 2001-10-15 | 2003-07-15 | Hercules Incorporated | Highly compressible ethylcellulose for tableting |
EP1443899B1 (en) | 2001-10-29 | 2010-08-18 | Ajinomoto Co., Inc. | Bowel cleansing agent |
DE10208335A1 (en) | 2002-02-27 | 2003-09-04 | Roehm Gmbh | Pharmaceutical form and process for its preparation |
US6946149B2 (en) | 2002-04-30 | 2005-09-20 | Braintree Laboratories, Inc. | Salt solution for colon cleansing |
DE10239161A1 (en) | 2002-08-27 | 2004-03-11 | Ludwig Kraemer | Stimulating gastric function without causing undesirable side-effects, using nutritional supplement containing vitamin C and magnesium |
GB0224909D0 (en) * | 2002-10-25 | 2002-12-04 | Norgine Europe Bv | Colon cleansing compositions |
WO2004039326A2 (en) | 2002-10-29 | 2004-05-13 | Transform Pharmaceuticals, Inc. | Propofol with cysteine |
JP2004323479A (en) | 2003-04-28 | 2004-11-18 | Ajinomoto Co Inc | Mild cathartic agent for constipation |
JP2004323456A (en) | 2003-04-28 | 2004-11-18 | Shimizu Pharmaceutical Co Ltd | Intestinal tract-cleaning preparation |
EP1663257B1 (en) | 2003-07-09 | 2009-01-07 | Braintree Laboratories, Inc. | Use of laxatives for treating irritable bowel syndrome |
CA2546019A1 (en) | 2003-11-17 | 2005-06-02 | Braintree Laboratories, Inc. | Therapeutic peg solution concentrate |
US7687075B2 (en) | 2003-11-19 | 2010-03-30 | Salix Pharmaceuticals, Ltd. | Colonic purgative composition with soluble binding agent |
US20050226906A1 (en) | 2004-04-08 | 2005-10-13 | Micro Nutrient, Llc | Nutrient system for individualized responsive dosing regimens |
GB0409104D0 (en) | 2004-04-23 | 2004-05-26 | Norgine Europe Bv | Compressed pharmaceutical compositions |
PL1750702T3 (en) | 2004-06-04 | 2011-04-29 | Braintree Laboratories Inc | Method of bowel cleansing |
GB0507167D0 (en) | 2005-04-08 | 2005-05-18 | Glaxosmithkline Consumer Healt | Composition |
AU2006244112B2 (en) | 2005-05-06 | 2011-02-17 | Salix Pharmaceuticals, Inc. | Polyethylene glycol colonic purgative composition |
WO2007037803A2 (en) | 2005-09-16 | 2007-04-05 | Eli Ehrenpreis | Water-soluble colonoscopy lubricant |
US20070082061A1 (en) * | 2005-10-07 | 2007-04-12 | Nelson Ayala | Reduction of saltiness with sweeteners |
CN1813674A (en) | 2005-12-12 | 2006-08-09 | 王冕 | Sodium vitamin C formulation for intravenous administration and its preparing method |
CN100476462C (en) | 2006-06-20 | 2009-04-08 | 刘彤 | Basal body of reflector, and fabricating method |
WO2009032538A1 (en) | 2007-08-31 | 2009-03-12 | C.B. Fleet Company, Inc. | Method of preventing nephrocalcinosis |
AU2008312465A1 (en) | 2007-10-17 | 2009-04-23 | Thomas Jefferson University | Bowel purgative and uses thereof |
DE102007052870A1 (en) | 2007-11-02 | 2009-05-07 | Sasol Germany Gmbh | Use of polyethylene glycol powders and compositions containing them |
CN101450074B (en) | 2007-11-30 | 2012-03-14 | 凌沛学 | Composition capable of greatly improving gastrointestinal tract function and preventing and treating astriction |
CN101496589A (en) | 2008-01-29 | 2009-08-05 | 北京康必得药业有限公司 | Dietary fiber chewing tablet |
US20090232943A1 (en) | 2008-03-12 | 2009-09-17 | Aly Gamay | Stabilized vitamin solutions; use thereof; process for their production; and formulations comprising the same |
US20090258090A1 (en) | 2008-04-11 | 2009-10-15 | Braintree Laboratories, Inc. | Colon cleansing solution |
EP2294012B1 (en) * | 2008-05-07 | 2014-07-09 | Salix Pharmaceuticals, Ltd. | Administration of a bowel cleanser and an antibiotic for the treatment of bowel disease |
CN101766563A (en) | 2008-12-29 | 2010-07-07 | 山东北大高科华泰制药有限公司 | Combination use method of water-soluble vitamin injection and sodium chloride injection |
US20100178360A1 (en) | 2009-01-13 | 2010-07-15 | Universite Libre De Bruxelles | Nutritive composition |
US20100255122A1 (en) * | 2009-04-02 | 2010-10-07 | Garren Mary L | Edible gelatin bowel preparation and bowel cleansing method |
WO2010123901A1 (en) | 2009-04-21 | 2010-10-28 | Bachwich Dale R | Colon lavage system |
WO2010144865A2 (en) * | 2009-06-12 | 2010-12-16 | Meritage Pharma, Inc. | Methods for treating gastrointestinal disorders |
AU2011101324B4 (en) | 2009-07-17 | 2012-01-19 | Norgine Bv | Improvements in and relating to colon cleansing compositions |
GB0912487D0 (en) * | 2009-07-17 | 2009-08-26 | Norgine Bv | Improvements in and relating to colon cleansing compositions |
GB0913295D0 (en) | 2009-07-30 | 2009-09-02 | Norgine Bv | Improvements in and relating to pharmaceutical compositions |
EP2322190B1 (en) * | 2009-11-02 | 2013-04-03 | Promefarm S.r.l. | Compositions for bowel cleansing and use thereof |
CN101766648B (en) | 2010-03-02 | 2012-01-11 | 舒泰神(北京)生物制药股份有限公司 | Polyethylene glycol electrolyte granular preparation and production method |
CA2792647A1 (en) | 2010-03-10 | 2011-09-15 | Nogra Pharma Limited | Compositions for colon lavage and methods of making and using same |
WO2012059724A1 (en) | 2010-11-04 | 2012-05-10 | Norgine Bv | Formulations comprising polyethylene glycol |
GB201018650D0 (en) | 2010-11-04 | 2010-12-22 | Norgine Bv | Methods and compositions |
DE202010016398U1 (en) | 2010-12-09 | 2011-04-28 | Norgine B.V. | Improvements in pharmaceutical compositions and in pharmaceutical compositions |
BR112013019360A2 (en) * | 2011-01-28 | 2017-03-28 | A Shaver William | ingredients, dry component of pharmaceutically acceptable low chloride oral colon cleansing formulation, aqueous electrolyte replacement base solution for use in colonic lavage, methods for cleaning the intestines of the patient, for preparing aqueous colon cleansing solution and to substantially increase the taste of colon cleansers and colon evacuation kits. |
EA201300864A1 (en) | 2011-01-31 | 2013-12-30 | Адзиномото Ко., Инк. | MULTI-CHAMBER CONTAINER |
ES2914034T3 (en) | 2011-01-31 | 2022-06-07 | Norgine Healthcare B V | Enhancements provided and associated with compositions |
GB201103942D0 (en) | 2011-03-08 | 2011-04-20 | Norgine Bv | Compositions |
TWI535461B (en) * | 2011-03-11 | 2016-06-01 | 諾金私人有限公司 | Colon cleansing solutions,compositions for preparing the solutions,kits comprising the compositions or solutions,and methods for preparing the solutions |
JP5708141B2 (en) | 2011-03-30 | 2015-04-30 | 味の素株式会社 | Formulation for oral administration for preparing solution for oral administration |
WO2013001315A1 (en) | 2011-06-30 | 2013-01-03 | Zernicka-Goetz Magdalena Dorota | Materials and methods for cell culture |
CN106526186A (en) | 2011-09-12 | 2017-03-22 | 克里蒂科斯有限责任公司 | Non-invasive method for detecting target molecules |
US20130102661A1 (en) | 2011-10-25 | 2013-04-25 | The Chinese University Of Hong Kong | Irrigation solutions containing ascorbic acid or its salts and use thereof |
EP2782581A4 (en) | 2011-10-27 | 2015-05-20 | Salix Pharmaceuticals Inc | Electrolyte purgatives |
US9149493B2 (en) | 2011-11-28 | 2015-10-06 | Alfa Wassermann Spa | Compositions for bowel cleansing and use thereof |
US9238075B2 (en) | 2011-12-07 | 2016-01-19 | Msm Innovations, Inc. | Method for bowel preparation |
CA2799881A1 (en) | 2011-12-20 | 2013-06-20 | Water Pik, Inc. | Nasal wash solution |
CN102600201B (en) | 2012-02-07 | 2014-07-16 | 舒泰神(北京)生物制药股份有限公司 | Pharmaceutical composition for relaxing bowels and purging intestines and preparation method of pharmaceutical composition |
KR101210831B1 (en) | 2012-02-10 | 2012-12-11 | 주식회사태준제약 | Colonic purgative composition comprising polyethylene glycol and vitamin c |
CN102805752B (en) | 2012-08-20 | 2014-04-02 | 深圳万和制药有限公司 | Compound polyethylene glycol electrolyte powder and preparation method thereof |
CN102805753B (en) | 2012-08-20 | 2014-09-24 | 深圳万和制药有限公司 | Medicinal composition containing polyethylene glycol and electrolyte |
CN102772427B (en) | 2012-08-20 | 2014-02-05 | 深圳万和制药有限公司 | Compound polyethylene glycol electrolyte composition |
ES2909386T3 (en) * | 2012-09-11 | 2022-05-06 | Norgine Bv | Compositions comprising polyethylene glycol and alkali or alkaline earth metal sulfates for use as colon cleansing compositions |
CN103550212A (en) | 2013-11-03 | 2014-02-05 | 王显著 | Picosulfate and ascorbic acid containing pharmaceutical composition |
CN103550249B (en) | 2013-11-09 | 2015-08-12 | 王显著 | A kind of pharmaceutical composition for INTESTINAL CLEANSING |
JP6295194B2 (en) | 2014-12-22 | 2018-03-14 | エルジー ディスプレイ カンパニー リミテッド | Mounting method of electronic components |
-
2013
- 2013-09-10 ES ES18210570T patent/ES2909386T3/en active Active
- 2013-09-10 PT PT182105700T patent/PT3473248T/en unknown
- 2013-09-10 SG SG10201702005VA patent/SG10201702005VA/en unknown
- 2013-09-10 AU AU2013314442A patent/AU2013314442C1/en active Active
- 2013-09-10 PL PL13762101T patent/PL2895163T3/en unknown
- 2013-09-10 EA EA201500320A patent/EA028866B1/en unknown
- 2013-09-10 CA CA2884472A patent/CA2884472C/en active Active
- 2013-09-10 SG SG11201501713XA patent/SG11201501713XA/en unknown
- 2013-09-10 HU HUE13762101A patent/HUE043605T2/en unknown
- 2013-09-10 EP EP13762101.7A patent/EP2895163B1/en active Active
- 2013-09-10 KR KR1020157009289A patent/KR101771586B1/en active IP Right Grant
- 2013-09-10 MY MYPI2019002190A patent/MY193378A/en unknown
- 2013-09-10 SG SG10202112138QA patent/SG10202112138QA/en unknown
- 2013-09-10 PT PT13762101T patent/PT2895163T/en unknown
- 2013-09-10 LT LTEP13762101.7T patent/LT2895163T/en unknown
- 2013-09-10 PL PL18210570.0T patent/PL3473248T3/en unknown
- 2013-09-10 KR KR1020217015401A patent/KR20210063445A/en active Application Filing
- 2013-09-10 SI SI201331478T patent/SI2895163T1/en unknown
- 2013-09-10 MY MYPI2015700728A patent/MY174758A/en unknown
- 2013-09-10 AR ARP130103214A patent/AR092500A1/en unknown
- 2013-09-10 DK DK13762101.7T patent/DK2895163T3/en active
- 2013-09-10 IN IN1704DEN2015 patent/IN2015DN01704A/en unknown
- 2013-09-10 MX MX2015003031A patent/MX359318B/en active IP Right Grant
- 2013-09-10 RS RS20190662A patent/RS58979B1/en unknown
- 2013-09-10 KR KR1020197034988A patent/KR102257207B1/en active IP Right Grant
- 2013-09-10 CA CA3116204A patent/CA3116204C/en active Active
- 2013-09-10 JP JP2015530448A patent/JP6655391B2/en active Active
- 2013-09-10 NZ NZ705499A patent/NZ705499A/en unknown
- 2013-09-10 DK DK18210570.0T patent/DK3473248T3/en active
- 2013-09-10 EP EP18210570.0A patent/EP3473248B1/en active Active
- 2013-09-10 KR KR1020237000981A patent/KR20230010844A/en not_active Application Discontinuation
- 2013-09-10 KR KR1020177023181A patent/KR20170098980A/en not_active Application Discontinuation
- 2013-09-10 CN CN201380058756.5A patent/CN105007915B/en active Active
- 2013-09-10 NZ NZ74398413A patent/NZ743984A/en unknown
- 2013-09-10 ME MEP-2019-160A patent/ME03413B/en unknown
- 2013-09-10 BR BR112015005270-3A patent/BR112015005270B1/en active IP Right Grant
- 2013-09-10 ES ES13762101T patent/ES2728459T3/en active Active
- 2013-09-10 WO PCT/EP2013/068738 patent/WO2014040994A1/en active Application Filing
- 2013-09-11 TW TW109103044A patent/TWI756623B/en active
- 2013-09-11 TW TW102132749A patent/TWI687238B/en active
- 2013-09-11 NL NL2011424A patent/NL2011424C2/en active
- 2013-10-09 UA UAA201503303A patent/UA116546C2/en unknown
-
2014
- 2014-03-10 US US14/202,098 patent/US20140186470A1/en not_active Abandoned
- 2014-03-24 US US14/223,127 patent/US8999313B2/en active Active
-
2015
- 2015-02-23 IL IL237377A patent/IL237377B/en active IP Right Grant
- 2015-03-03 ZA ZA2015/01415A patent/ZA201501415B/en unknown
- 2015-03-09 SG SG10201807427RA patent/SG10201807427RA/en unknown
- 2015-03-09 JP JP2016556837A patent/JP6557675B2/en active Active
- 2015-03-09 MX MX2016011256A patent/MX2016011256A/en unknown
- 2015-03-09 CN CN201580013447.5A patent/CN106102738A/en active Pending
- 2015-03-09 ES ES15709665T patent/ES2831412T3/en active Active
- 2015-03-13 US US14/657,495 patent/US9326969B2/en active Active
- 2015-07-27 HK HK15107141.6A patent/HK1206604A1/en unknown
- 2015-11-30 US US14/954,290 patent/US20160184263A1/en not_active Abandoned
-
2016
- 2016-04-28 US US15/141,054 patent/US9707297B2/en active Active
- 2016-06-02 ZA ZA2016/03747A patent/ZA201603747B/en unknown
-
2017
- 2017-03-09 US US15/454,132 patent/US10016504B2/en active Active
- 2017-05-25 US US15/605,617 patent/US10918723B2/en active Active
-
2018
- 2018-06-28 AU AU2018204694A patent/AU2018204694C1/en active Active
- 2018-07-06 US US16/028,819 patent/US20180311361A1/en not_active Abandoned
-
2019
- 2019-05-31 CY CY20191100580T patent/CY1121668T1/en unknown
- 2019-06-04 HR HRP20191007TT patent/HRP20191007T1/en unknown
- 2019-08-29 IL IL26902419A patent/IL269024A/en active IP Right Grant
-
2020
- 2020-01-31 JP JP2020015456A patent/JP7277396B2/en active Active
-
2021
- 2021-07-23 US US17/384,227 patent/US12083179B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG10201807427RA (en) | Method of cleansing the colon | |
MX2016000173A (en) | Systems and methods for tracking and presenting tinnitus therapy data. | |
MX2015015907A (en) | Objective non-invasive method for quantifying degree of itch using psychophysiological measures. | |
EP2967368A4 (en) | Apparatus and methods for computing cardiac output of a living subject via applanation tonometry | |
PH12015502302B1 (en) | Treatment of allergic rhinitis using a combination of mometasone and olopatadine | |
MX364220B (en) | Methods of treating fibrosis. | |
MX2020002004A (en) | Non-invasive diagnostic of non-alcoholic fatty liver diseases, non-alcoholic steatohepatitis and/or liver fibrosis. | |
WO2016105516A8 (en) | Methods of using smad7 antisense oligonucleotides | |
EP3398605A4 (en) | Medicinal composition for improving prognosis after restart of patient's own heartbeat | |
SG10201804772UA (en) | Method of imaging living tissue | |
WO2013059233A3 (en) | Thermoresponsive compositions for dermatological use and methods thereof | |
FR3017624B1 (en) | PREDICTIVE METHOD FOR CHARACTERIZING THE RADIOSENSITIVITY AND TISSUE REACTION OF A PATIENT TO THERAPEUTIC IONIZING RADIATION | |
MX2015012455A (en) | Method for the treatment of fatty liver disease. | |
TN2015000315A1 (en) | Methods of treating cardiovascular indications | |
MX2021005225A (en) | Method of cleansing the colon. | |
UA71543U (en) | Method for surgical treatment of oroantral fistula in deficit of tissues at distal site of defect | |
MX2016002139A (en) | Pharmaceutical composition and use of diethyl (2-cyanoethyl)phosphonate. | |
UA91703U (en) | Indrikson-chakii method for making thick hair | |
UA72157U (en) | Method for treating initial forms of cerebral vascular diseases | |
UA74394U (en) | Indrikson's method for treating pyodermatitis | |
Riad | Erythema, pruritus and skin crusting: case report | |
UA91721U (en) | Indrikson's method for treating acne of face | |
UA64165U (en) | Method for treating patients with injuries of soft tissues in limbs | |
UA97125U (en) | METHOD OF NON-MEDICINAL TREATMENT, REHABILITATION AND PREVENTION WITH THE USE OF DOLPHINS | |
UA101380U (en) | Method of treating of the acne on the face and the back by indrikson |